NCT05345444 2026-03-25
RTIRE
Weill Medical College of Cornell University
Phase NA Active not recruiting
Clinical Trials
78 trialsNCT04526730 2026-02-20
Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT06378047 2026-02-09
Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT07328243 2026-01-09
IRE-TCLN
First Affiliated Hospital of Zhejiang University
Phase NA Recruiting
NCT07306273 2025-12-29
IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy
Ruijin Hospital
Phase 2 Recruiting
NCT06451445 2025-12-11
WIRED
University Health Network, Toronto
Phase NA Recruiting
NCT03484299 2025-10-29
Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
University of Louisville
Phase 1 Recruiting
NCT06205849 2025-07-25
Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer
University of California, San Diego
Phase 1 Recruiting
NCT05555342 2025-05-14
A Novel Method for Treating Lung Met w/Combo of Electric Fields & Rad Therapy: A Single-Arm
University of California, Irvine
Phase EARLY_PHASE1 Completed
NCT04276857 2025-05-13
SMART
University of Saskatchewan
Phase NA Recruiting
NCT05513443 2025-01-20
PRIS
Karolinska Institutet
Phase NA Recruiting
NCT04760327 2024-10-17
GynECT
Institute of Oncology Ljubljana
Phase 2 Recruiting
NCT06185556 2024-08-23
COLDFIRE-III
Amsterdam UMC, location VUmc
Phase 2/3 Recruiting
NCT06047015 2024-08-09
Irreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal Cancer
University of Saskatchewan
Phase 1/2 Not yet recruiting
NCT03630640 2024-07-31
NIVOLEP
Assistance Publique - Hôpitaux de Paris
Phase 2 Completed
NCT05609656 2024-06-03
ELI
Zealand University Hospital
Phase 2 Terminated
NCT05435053 2023-09-15
CHECKPOINT
Zealand University Hospital
Phase 2 Terminated
NCT03823131 2023-05-09
Optimizing Antitumor Immunity Using Plasmid Electroporation, Pembrolizumab, and Epacadostat
University of California, San Francisco
Phase 2 Terminated
NCT01939665 2022-12-20
PANFIRE
Amsterdam UMC, location VUmc
Phase 1/2 Completed
NCT02082782 2022-12-20
COLDFIRE-2
Amsterdam UMC, location VUmc
Phase 2 Completed
NCT02791503 2022-12-20
CROSSFIRE
Amsterdam UMC, location VUmc
Phase NA Completed
NCT04612530 2022-12-20
PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer
Amsterdam UMC, location VUmc
Phase 1 Unknown
NCT05512663 2022-08-23
Safety and Efficacy Evaluation of Transperineal Irreversible Electroporation (IRE) of Anterior Prostate Cancer
Jewish General Hospital
Phase NA Unknown
NCT03257150 2022-08-11
A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer
University Health Network, Toronto
Phase NA Completed
NCT04717687 2022-07-13
HOPE
Poitiers University Hospital
Phase NA Withdrawn
NCT04835402 2022-03-09
EPIC-1
Aalborg University Hospital
Phase 2 Unknown
NCT05046262 2021-09-16
Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study
Bispebjerg Hospital
Phase 3 Unknown
NCT02329106 2021-09-05
Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02333773 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02335112 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02335827 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02425059 2021-09-05
Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430597 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430610 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430623 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430636 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430662 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430675 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430688 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430701 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430753 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430766 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT02430779 2021-09-05
IRE
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT03337997 2021-05-06
A Pilot Study of IRE for Resectable Pancreatic Cancer
University of Saskatchewan
Phase NA Withdrawn
NCT04093141 2021-04-01
CHEMOFIRE-2
Aalborg University Hospital
Phase NA Unknown
NCT04404647 2021-03-26
Irreversible Electroporation of Unresectable Liver Tumors
Aalborg University Hospital
Phase NA Withdrawn
NCT04816045 2021-03-25
Neoadjuvant Electrochemotherapy for Colorectal Cancer - a Randomized Controlled Trial
Zealand University Hospital
Phase 1/2 Unknown
NCT02981719 2021-01-22
Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou
Phase NA Completed
NCT01835977 2020-12-16
Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer
Clinical Research Office of the Endourological Society
Phase 2 Unknown
NCT03040453 2020-11-30
IRAL
Karolinska Institutet
Phase NA Withdrawn